RecruitingNCT05372861
Nanopore Sequencing in Ophthalmology
Nanopore Sequencing in Ophthalmology - a Paradigm Shift in Pathogen Determination?
Sponsor
Medical University of Graz
Enrollment
20 participants
Start Date
Apr 22, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
In this pilot study, the feasibility of the Oxford Nanopore MinION to identify pathogens from vitrectomy samples in eyes with endophthalmitis shall be assessed. The MinION is a low cost commercially available device for DNA/ RNA analysis that, in studies, has been used for pathogen determination in various infectious diseases as well as for the genetic characterization of hematologic tumors.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Inclusion Criteria1
- Eyes of patients with endophthalmitis
Exclusion Criteria2
- No informed consent possible
- Participation in other studies
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05372861